Asakura H - Search Results

1

Classifying types of disseminated intravascular coagulation: clinical and animal models.

Asakura H. Asakura H. J Intensive Care. 2014 Mar 6;2(1):20. doi: 10.1186/2052-0492-2-20. eCollection 2014. J Intensive Care. 2014. PMID: 25520834 Free PMC article. Review.

2

Changes in levels of t-PA and alpha 2PI-plasmin complex in plasma in patients with DIC.

Matsuda T, Asakura H, Ito K, Saito M, Jokaji Y, Uotani C, Kumabashiri I. Matsuda T, et al. Among authors: asakura h. Thromb Res Suppl. 1988;8:143-51. doi: 10.1016/0049-3848(88)90163-6. Thromb Res Suppl. 1988. PMID: 3144764

3

[Classification and treatment of DIC].

Asakura H, Saito M. Asakura H, et al. Rinsho Ketsueki. 1995 Apr;36(4):314-9. Rinsho Ketsueki. 1995. PMID: 7783336 Japanese.

4

Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.

Yamazaki M, Asakura H, Aoshima K, Saito M, Jokaji H, Uotani C, Kumabashiri I, Morishita E, Ikeda T, Matsuda T. Yamazaki M, et al. Among authors: asakura h. Thromb Haemost. 1994 Sep;72(3):392-6. Thromb Haemost. 1994. PMID: 7855790

5

Changes in plasma levels of prothrombin fragment F 1 + 2 in cases of disseminated intravascular coagulation.

Asakura H, Shiratori Y, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, Yamazaki M, Matsuda T. Asakura H, et al. Acta Haematol. 1993;89(1):22-5. doi: 10.1159/000204477. Acta Haematol. 1993. PMID: 8480481

6

Role of tissue factor in disseminated intravascular coagulation.

Asakura H, Kamikubo Y, Goto A, Shiratori Y, Yamazaki M, Jokaji H, Saito M, Uotani C, Kumabashiri I, Morishita E, et al. Asakura H, et al. Thromb Res. 1995 Nov 1;80(3):217-24. doi: 10.1016/0049-3848(95)00170-v. Thromb Res. 1995. PMID: 8578548

7

[Analysis of behaviors of plasma tissue factor and tissue factor pathway inhibitor in patients with various diseases].

Saito M, Morishita E, Asakura H, Jokaji H, Uotani C, Kumabashiri I, Yamazaki M, Aoshima K, Matsuda T. Saito M, et al. Among authors: asakura h. Rinsho Ketsueki. 1996 Sep;37(9):794-8. Rinsho Ketsueki. 1996. PMID: 8914465 Japanese.

8

Treatment of disseminated intravascular coagulation (DIC) with all-trans retinoic acid in an endotoxin-induced rat model.

Aoshima K, Asakura H, Yamazaki M, Saito M, Kumabashiri I, Morishita E, Ontachi Y, Mizutani T, Ichino T, Matsuda T. Aoshima K, et al. Among authors: asakura h. Semin Thromb Hemost. 1998;24(3):227-31. doi: 10.1055/s-2007-995846. Semin Thromb Hemost. 1998. PMID: 9701452

9

An enhanced fibrinolysis prevents the development of multiple organ failure in disseminated intravascular coagulation in spite of much activation of blood coagulation.

Asakura H, Ontachi Y, Mizutani T, Kato M, Saito M, Kumabashiri I, Morishita E, Yamazaki M, Aoshima K, Nakao S. Asakura H, et al. Crit Care Med. 2001 Jun;29(6):1164-8. doi: 10.1097/00003246-200106000-00015. Crit Care Med. 2001. PMID: 11395595

10

All-trans retinoic acid is partially effective against lipopolysaccharide-induced but not against tissue-factor-induced disseminated intravascular coagulation in rat models.

Asakura H, Aoshima K, Ichino T, Suga Y, Saito M, Morishita E, Yamazaki M, Ontachi Y, Mizutani T, Kato M, Miyamoto KI, Nakao S. Asakura H, et al. Blood Coagul Fibrinolysis. 2001 Jun;12(4):301-6. doi: 10.1097/00001721-200106000-00011. Blood Coagul Fibrinolysis. 2001. PMID: 11460014

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results